Lumos Pharma Inc reports results for the quarter ended in June - Earnings Summary

Lumos Pharma

10/08/2022 24:40

* Lumos Pharma Inc  LUMO.OQ  reported a quarterly adjusted
loss
of 94 cents​​ per share for the quarter ended in June. The mean
expectation of seven analysts for the quarter was for a loss
of 99 cents per share.
    * Revenue rose 3,930% to $403.00 thousand from a year ago;
analysts expected $15.86 thousand. 
    * Lumos Pharma Inc's reported EPS for the quarter was a loss
of 94
cents​.
    * The mean earnings estimate of analysts had fallen by
about 1.2%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Lumos Pharma Inc shares had risen by 11.0% this
quarter and
gained 23.4% so far this year.
    * The company reported a quarterly loss of $7.84 million.
    * Wall Street's median 12-month price target for Lumos
Pharma Inc
is $25.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 7 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data August 9
at 11:40 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2022      -0.99          -0.94          Beat
 Mar. 31 2022      -0.89          -0.92          Missed
 Dec. 31 2021      -0.92          -0.67          Beat
 Sep. 30 2021      -1.07          -0.90          Beat